Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

Review

Current status of and strategies for hepatitis C control in South Korea

Beom Kyung Kim, Eun Sun Jang, Jeong Han Kim, Soo Young Park, Song Vogue Ahn, Hyung Joon Kim, Do Young Kim

Clin Mol Hepatol. 2017;23(3):212-218. Published online September 19, 2017

DOI: https://doi.org/10.3350/cmh.2017.0105

View: 8005 Download: 232 Web of Science: 17 Crossref: 19

Original Article

Clinical impact of the early alanine amininotransferase flare during tenofovir monotherapy in treatment-naïve patients with chronic hepatitis B

Hee Yeon Seo, Han Ah Lee, Soon Young Ko, Joon Ho Wang, Jeong Han Kim, Won Hyeok Choe, So Young Kwon

Clin Mol Hepatol. 2017;23(2):154-159. Published online May 8, 2017

DOI: https://doi.org/10.3350/cmh.2016.0067

View: 7364 Download: 170 Web of Science: 7 Crossref: 7

The efficacy of tenofovir-based therapy in patients showing suboptimal response to entecavir-adefovir combination therapy

Jeong Han Kim, Sung Hyun Ahn, Soon Young Ko, Won Hyeok Choe, Kyun-Hwan Kim, So Young Kwon

Clin Mol Hepatol. 2016;22(2):241-249. Published online June 15, 2016

DOI: https://doi.org/10.3350/cmh.2015.0053

View: 9747 Download: 138 Web of Science: 4 Crossref: 4

Case Report

Portal biliopathy treated with endoscopic biliary stenting

Sung Jin Jeon, Jae Ki Min, So Young Kwon, Jun Hyun Kim, Sun Young Moon, Kang Hoon Lee, Jeong Han Kim, Won Hyeok Choe, Young Koog Cheon, Tae Hyung Kim, Hee Sun Park

Clin Mol Hepatol. 2016;22(1):172-176. Published online March 28, 2016

DOI: https://doi.org/10.3350/cmh.2016.22.1.172

View: 9578 Download: 105 Web of Science: 3 Crossref: 4

Editorial

What we know about paracentesis induced circulatory dysfunction?

Jeong Han Kim

Clin Mol Hepatol. 2015;21(4):349-351. Published online December 24, 2015

DOI: https://doi.org/10.3350/cmh.2015.21.4.349

View: 9645 Download: 163 Web of Science: 3 Crossref: 4

Case Report

Reversible splenial lesion on the corpus callosum in nonfulminant hepatitis A presenting as encephalopathy

Soon Young Ko, Byung Kook Kim, Dong Wook Kim, Jeong Han Kim, Won Hyeok Choe, Hee Yeon Seo, So Young Kwon

Clin Mol Hepatol. 2014;20(4):398-401. Published online December 24, 2014

DOI: https://doi.org/10.3350/cmh.2014.20.4.398

View: 6952 Download: 117 Web of Science: 11 Crossref: 10

A synchronous hepatocellular carcinoma and renal cell carcinoma treated with radio-frequency ablation

Yoon Serk Lee, Jeong Han Kim, Hyeon Young Yoon, Won Hyeok Choe, So Young Kwon, Chang Hong Lee

Clin Mol Hepatol. 2014;20(3):306-309. Published online September 25, 2014

DOI: https://doi.org/10.3350/cmh.2014.20.3.306

View: 6127 Download: 48 Web of Science: 6 Crossref: 5

Original Article

Hepatitis B surface antigen levels at 6 months after treatment can predict the efficacy of lamivudine-adefovir combination therapy in patients with lamivudine-resistant chronic hepatitis B

Jeong Han Kim, Hee Won Moon, Soon Young Ko, Won Hyeok Choe, So Young Kwon

Clin Mol Hepatol. 2014;20(3):274-282. Published online September 25, 2014

DOI: https://doi.org/10.3350/cmh.2014.20.3.274

View: 6625 Download: 43 Web of Science: 3 Crossref: 2

Prevalence of renal dysfunction in patients with cirrhosis according to ADQI-IAC working party proposal

Yun Jung Choi, Jeong Han Kim, Ja Kyung Koo, Cho I Lee, Ji Young Lee, Jae Hoon Yang, Soon Young Ko, Won Hyeok Choe, So Young Kwon, Chang Hong Lee

Clin Mol Hepatol. 2014;20(2):185-191. Published online June 30, 2014

DOI: https://doi.org/10.3350/cmh.2014.20.2.185

View: 9196 Download: 111 Web of Science: 31 Crossref: 26

Alcoholic fatty liver disease elevates estimated coronary heart disease risk to levels comparable with those of nonalcoholic fatty liver disease in the Korean population: a cross-sectional study

Hai Jin Kim, Jeong Han Kim, Won Hyeok Choe, So Young Kwon, Chang Hong Lee

Clin Mol Hepatol. 2014;20(2):154-161. Published online June 30, 2014

DOI: https://doi.org/10.3350/cmh.2014.20.2.154

View: 7199 Download: 72 Web of Science: 6 Crossref: 6

The refit model for end-stage liver disease-Na is not a better predictor of mortality than the refit model for end-stage liver disease in patients with cirrhosis and ascites

Jun Jae Kim, Jeong Han Kim, Ja Kyung Koo, Yun Jung Choi, Soon Young Ko, Won Hyeok Choe, So Young Kwon

Clin Mol Hepatol. 2014;20(1):47-55. Published online March 26, 2014

DOI: https://doi.org/10.3350/cmh.2014.20.1.47

View: 6123 Download: 47 Web of Science: 5 Crossref: 2

HBsAg level and clinical course in patients with chronic hepatitis B treated with nucleoside analogue: five years of follow-up data

Jeong Han Kim, Yun Jung Choi, Hee Won Moon, Soon Young Ko, Won Hyeok Choe, So Young Kwon

Clin Mol Hepatol. 2013;19(4):409-416. Published online December 28, 2013

DOI: https://doi.org/10.3350/cmh.2013.19.4.409

View: 6150 Download: 61 Crossref: 6

Lamivudine plus adefovir combination therapy for lamivudine resistance in hepatitis-B-related hepatocellular carcinoma patients

Jeong Han Kim, Soon Young Ko, Won Hyeok Choe, So Young Kwon, Chang Hong Lee

Clin Mol Hepatol. 2013;19(3):273-279. Published online September 30, 2013

DOI: https://doi.org/10.3350/cmh.2013.19.3.273

View: 6324 Download: 40 Crossref: 1

Clinical outcomes of balloon-occluded retrograde transvenous obliteration for the treatment of gastric variceal hemorrhage in Korean patients with liver cirrhosis: a retrospective multicenter study

Se Young Jang, Go Heun Kim, Soo Young Park, Chang Min Cho, Won Young Tak, Jeong Han Kim, Won Hyeok Choe, So Young Kwon, Jae Myeong Lee, Sang Gyune Kim, Dae Yong Kim, Young Seok Kim, Se-Ok Lee, Yang Won Min, Joon Hyeok Lee, Seung Woon Paik, Byung Chul Yoo, Jae Wan Lim, Hong Joo Kim, Yong Kyun Cho, Joo Hyun Sohn, Jae Yoon Jeong, Yu Hwa Lee, Tae Yeob Kim, Young Oh Kweon

Clin Mol Hepatol. 2012;18(4):368-374. Published online December 21, 2012

DOI: https://doi.org/10.3350/cmh.2012.18.4.368

View: 9035 Download: 81 Crossref: 32

Clinical features of acute viral hepatitis B in Korea: a multi-center study

Hye Jin Choi, Soon Young Ko, Won Hyeok Choe, Yeon Seok Seo, Ji Hoon Kim, Kwan Soo Byun, Young Seok Kim, Seung Up Kim, Soon Koo Baik, Jae Youn Cheong, Tae Yeob Kim, Oh Sang Kwon, Jeong Han Kim, Chang Hong Lee, So Young Kwon

Clin Mol Hepatol. 2011;17(4):307-312. Published online December 26, 2011

DOI: https://doi.org/10.3350/kjhep.2011.17.4.307

View: 8410 Download: 74 Crossref: 14

Virologic response is not durable after adefovir discontinuation in lamivudine-resistant chronic hepatitis B patients

Young Kul Jung, Jong Eun Yeon, Kwang Gyun Lee, Eun Seok Jung, Jeong Han Kim, Ji Hoon Kim, Yeon Seok Seo, Hyung Joon Yim, Sun Ho Um, Ho Sang Ryu, Kwan Soo Byun

Clin Mol Hepatol. 2011;17(4):261-267. Published online December 26, 2011

DOI: https://doi.org/10.3350/kjhep.2011.17.4.261

View: 6324 Download: 48 Crossref: 10

Case Report

Clinical courses after administration of oral corticosteroids in patients with severely cholestatic acute hepatitis A; three cases

Eileen L. Yoon, Hyung Joon Yim, Seung Young Kim, Jeong Han Kim, Ju-Han Lee, Young Sun Lee, Hyun Jung Lee, Sung Woo Jung, Sang Woo Lee, Jai Hyun Choi

Clin Mol Hepatol. 2010;16(3):329-333. Published online September 30, 2010

DOI: https://doi.org/10.3350/kjhep.2010.16.3.329

View: 7034 Download: 85 Crossref: 7

1 |

Viewed By 5365	Prognostic value of ultra-low-pass whole-genome sequencing of circulating tumor DNA in hepatocellular carcinoma under systemic treatment
Viewed By 5324	MAFLD: How is it different from NAFLD?
Viewed By 5210	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Viewed By 3895	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Viewed By 3857	Global incidence and prevalence of nonalcoholic fatty liver disease

Cited By 114	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Cited By 103	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Cited By 76	Global incidence and prevalence of nonalcoholic fatty liver disease
Cited By 65	Forecasted 2040 global prevalence of nonalcoholic fatty liver disease using hierarchical bayesian approach
Cited By 52	MAFLD: How is it different from NAFLD?

Search